Latest news from BIA

View all news
BIA blog
27 Mar 23
BIA Blog

CEO Update | 27 March 2023

The UK Government published last week the long-awaited response to the consultation on proposals to improve the UK clinical trials legislation, with a foreword by life science champions Sir John Bell and Sir Jon Symonds. These reforms represent the biggest overhaul in UK clinical trials regulation in over 20 years and will make the UK one of the best countries to conduct clinical research for the benefit of patients and the life sciences sector. Continue reading for details on upcoming events, UK Parliament scrutiny of SVB Collapse, and more.

27 Mar 23
BIA Blog

Revolutionising healthcare with data-driven innovation

Meet Danny Bosch, Associate Director of Business Development and Commercial at Imperial College Health Partners (ICHP). In his blog, Danny details how ICHP are working towards creating healthier populations, by unlocking the potential of innovation and supporting NHS and industry. 

20 Mar 23
BIA Blog

Unlocking the power of Virtual Reality to overcome anxiety and phobias

XR Therapeutics is a start-up company, spun out of Newcastle University, helping people to overcome their phobias or anxiety using Virtual Reality technology. We spoke with Penny Day, Head of Operations, about the role of virtual reality in mental health treatment, and how XR is making waves in this space.

20 Mar 23
BIA Blog

CEO Update | 20 March 2023

The Budget last week had major wins for BIA members including changes to R&D tax credits rates for loss-making SMEs. Read our press release and Martin’s analysis blog. This is a major, major win for a BIA campaign and wouldn’t have happened without member engagement and perseverance. Many thanks to all who helped – this non dilutive government co-investment will make all the difference as you crowd in private sector investment.

See More

 

Member News
28 Mar 23
Member News

Companies supercharged with £277m in government and private investment through the Life Sciences Innovative Manufacturing Fund

Four life sciences companies from across the UK will benefit from the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants.

23 Mar 23
Member News

Macomics and Ono Pharmaceutical partner to discover and develop macrophage-targeting antibody therapy for the treatment of cancer

Worldwide drug discovery collaboration agreement with Ono to develop new antibody drugs against a novel macrophage target of interest in immuno-oncology

21 Mar 23
Member News

Brainomix receives FDA clearance for its flagship stroke AI imaging software

The Oxford, UK headquartered company, long established as a market leader in Europe and a pioneer in the development of innovative stroke AI solutions, is now poised to take its transformative technology to US stroke centers

16 Mar 23
Member News

CF AMR Syndicate launches £3 million Collaborative Discovery Programme

Funding new antimicrobials to treat lung infections in people with Cystic Fibrosis

See More

 

Press Releases
27 Mar 23
Press Release

BIA launched first of its kind Diversity and Inclusion report for UK biotech and life sciences

The importance of building a thriving, diverse workplace is a widely recognised priority across all industries. The first of its kind sector data analysis by the BioIndustry Association (BIA) demonstrates strong inclusivity and an overall level of diversity in talent working within the UK innovative life sciences and biotech sector. The new state of the nation report, Diversity and Inclusion in UK Biotech, also reveals significant diversity gaps across disciplines, management levels and demographic traits which require action at both a company and sector level.

15 Mar 23
Press Release

Chancellor gives boost to medical innovation and life sciences industry in Spring Budget

The UK’s Chancellor, Jeremy Hunt, has announced a special higher R&D tax relief rate for the UK’s most innovative businesses in his Spring Budget today (15 March). The UK’s trade association for innovative life sciences and biotech, the UK BioIndustry Association (BIA), has warmly welcomed the announcement.

13 Feb 23
Press Release

Statement on Silicon Valley Bank rescue package

Steve Bates OBE, CEO of the BIA, said on the sale of the Silicon Valley Bank UK to HSBC announced by the Bank of England, in consultation with the Prudential Regulation Authority (PRA), HM Treasury (HMT) and the Financial Conduct Authority (FCA).

26 Jan 23
Press Release

Pharma looks to UK for innovation as global economic uncertainty hits fundraising

As global macroeconomic uncertainty hit fundraising across all sectors, investment in UK biotech fell from the all-time highs seen in 2021, new analysis from the UK BioIndustry Association (BIA) and data and insights company Clarivate shows. However, global pharma and investors looked to UK innovation to strengthen their product pipelines, with UK biotechs being acquired at a premium and others achieving pivotal milestones in their development.

See More

 

The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.

Explore opportunities to influence, connect and save with the BIA.

Influence

Influence

 Connect

Connect

 Save

Save 

policymakers, ensuring your voice is heard on the matters that are critical to the success of your organisation

with the UK ecosystem
through industry-leading events, expert committees and overseas missions

money with the BIA Business Solutions purchasing programme, helping you start, grow and deliver world-changing innovation
 
Learn more about BIA Membership
 
 
See who's in our Membership Directory